MYC and central nervous system cancer: A telomestatin derivative named S2T1-6OTD binds to the G-quadruplex structure in the c-Myc promoter, inhibiting its expression and activity; growth arrest and apoptosis induction in brain cancer cell lines were observed, including glioma [411] (Table 1).